Author:
Palmer Andrew J.,Valentine William J.,Ray Joshua A.,Roze Stephane,Muszbek Noemi
Publisher
Springer Science and Business Media LLC
Subject
Health Policy,Economics, Econometrics and Finance (miscellaneous)
Reference22 articles.
1. Ritz, E., Rychlik, I., Locatelli, F., Halimi, S.: End-stage renal failure in type 2 diabetes: a medical catastrophe of worldwide dimensions. Am. J. Kidney. Dis. 34(5), 795–808 (1999)
2. Adeghate, E., Schattner, P., Peter, A., Dunn, E., Donath, T.: Diabetes mellitus and its complications in a Hungarian population. Arch. Physiol. Biochem. 109(3), 281–291 (2001)
3. Molnar, M., Wittmann, I., Nagy, J.: Prevalence, course and risk factors of diabetic nephropathy in type-2 diabetes mellitus. Med. Sci. Monit. 6(5), 929–936 (2000)
4. Parving, H.H., Lehnert, H., Brochner-Mortensen, J., Gomis, R., Andersen, S., Arner, P.: The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes. N. Engl. J. Med. 345(12), 910–912 (2001)
5. Lewis, E.J., Hunsicker, L.G., Clarke, W.R., Berl, T., Pohl, M.A., Lewis, J.B., et al.: Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. N. Engl. J. Med. 345(12), 851–860 (2001)
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献